Jeff Hutchins, PhD, discusses current clinical trials that are investigating whether some patients with non-small cell lung cancer may qualify for an immune-oncology therapy treatment regimen that is...
In part 1 of 3 of this video series, Pulmonology Consultant Advisory Board Member Michael Niederman, MD, discusses the long-lasting impacts that the COVID-19 pandemic will have on the outpatient experience....
